Skip to main content
Erschienen in: Journal of Inherited Metabolic Disease 6/2015

01.11.2015 | Original Article

Alternative nighttime nutrition regimens in glycogen storage disease type I: a controlled crossover study

verfasst von: Michel Hochuli, Emanuel Christ, Fabian Meienberg, Roger Lehmann, Jan Krützfeldt, Matthias R. Baumgartner

Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 6/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Traditional approaches for nighttime glycemic control in glycogen storage disease type I (GSDI) include continuous tube feeding, or ingestion of uncooked corn starch (CS) at bedtime. A modified corn starch (MCS) has been shown to prolong euglycemia in some patients. The aim of this study was to evaluate whether stable nighttime glucose control can be achieved with other types of slowly digested carbohydrates in adult GSDI patients.

Methods

In this cross-over study, nocturnal glucose control and fasting times were assessed with three different nocturnal nutrition regimens in five patients, using continuous glucose monitoring (CGMS) in an outpatient everyday life setting. For each patient, continuous glucose profiles were measured after ingestion of (1) CS, (2) MCS or (3) a pasta meal at bedtime, during 5 to 6 consecutive nights for each regimen.

Results

Stable nocturnal glucose control was achieved for all patients with a pasta meal, with a mean duration of glycemia >3.5 mmol/l of 7.6 h (range 5.7-10.8), and >4 mmol/l of 7 h (5.2-9.2), similar to CS and MCS. Fasting glucose before breakfast on workdays (after 7.1 ± 0.8 h) was not significantly different between the three interventions (CS 4.1 ± 0.5 mmol/l, MCS 4.6 ± 0.7 mmol/l, pasta 4.3 ± 0.9 mmol/l). During prolonged fasting on weekends, longer duration of normoglycemia was achieved with CS or MCS than with pasta.

Conclusion

Consumption of cooked pasta is a suitable and more palatable alternative to uncooked corn starch to achieve nighttime glucose control in adult patients with GSDI.
Literatur
Zurück zum Zitat Aravind N, Sissons M, Fellows CM, Blazek J, Gilbert EP (2013) Optimisation of resistant starch II and III levels in durum wheat pasta to reduce in vitro digestibility while maintaining processing and sensory characteristics. Food Chem 136:1100–1109CrossRefPubMed Aravind N, Sissons M, Fellows CM, Blazek J, Gilbert EP (2013) Optimisation of resistant starch II and III levels in durum wheat pasta to reduce in vitro digestibility while maintaining processing and sensory characteristics. Food Chem 136:1100–1109CrossRefPubMed
Zurück zum Zitat Bhattacharya K (2011) Dietary dilemmas in the management of glycogen storage disease type I. J Inherit Metab Dis 34:621–629CrossRefPubMed Bhattacharya K (2011) Dietary dilemmas in the management of glycogen storage disease type I. J Inherit Metab Dis 34:621–629CrossRefPubMed
Zurück zum Zitat Bhattacharya K, Orton RC, Qi X et al (2007) A novel starch for the treatment of glycogen storage diseases. J Inherit Metab Dis 30:350–357CrossRefPubMed Bhattacharya K, Orton RC, Qi X et al (2007) A novel starch for the treatment of glycogen storage diseases. J Inherit Metab Dis 30:350–357CrossRefPubMed
Zurück zum Zitat Bjorck I, Granfeldt Y, Liljeberg H, Tovar J, Asp NG (1994) Food properties affecting the digestion and absorption of carbohydrates. Am J Clin Nutr 59:699s–705sPubMed Bjorck I, Granfeldt Y, Liljeberg H, Tovar J, Asp NG (1994) Food properties affecting the digestion and absorption of carbohydrates. Am J Clin Nutr 59:699s–705sPubMed
Zurück zum Zitat Chen Y-T, Kishnani PS, Koeberl D (2013) Glycogen storage diseases. In: Beaudet AL, Vogelstein B, Kinzler KW et al (eds) The online metabolic and molecular bases of inherited disease New York. The McGraw-Hill Companies, Inc., NY Chen Y-T, Kishnani PS, Koeberl D (2013) Glycogen storage diseases. In: Beaudet AL, Vogelstein B, Kinzler KW et al (eds) The online metabolic and molecular bases of inherited disease New York. The McGraw-Hill Companies, Inc., NY
Zurück zum Zitat Chou JY, Jun HS, Mansfield BC (2010) Glycogen storage disease type I and G6Pase-beta deficiency: etiology and therapy. Nat Rev Endocrinol 6:676–688PubMedCentralCrossRefPubMed Chou JY, Jun HS, Mansfield BC (2010) Glycogen storage disease type I and G6Pase-beta deficiency: etiology and therapy. Nat Rev Endocrinol 6:676–688PubMedCentralCrossRefPubMed
Zurück zum Zitat Correia CE, Bhattacharya K, Lee PJ et al (2008) Use of modified cornstarch therapy to extend fasting in glycogen storage disease types Ia and Ib. Am J Clin Nutr 88:1272–1276PubMedCentralPubMed Correia CE, Bhattacharya K, Lee PJ et al (2008) Use of modified cornstarch therapy to extend fasting in glycogen storage disease types Ia and Ib. Am J Clin Nutr 88:1272–1276PubMedCentralPubMed
Zurück zum Zitat Fardet A, Abecassis J, Hoebler C et al (1999) Influence of technological modifications of the protein network from pasta on in vitro starch degradation. J Cereal Sci 30:133–145CrossRef Fardet A, Abecassis J, Hoebler C et al (1999) Influence of technological modifications of the protein network from pasta on in vitro starch degradation. J Cereal Sci 30:133–145CrossRef
Zurück zum Zitat Kasapkara CS, Cinasal Demir G, Hasanoglu A, Tumer L (2014) Continuous glucose monitoring in children with glycogen storage disease type I. Eur J Clin Nutr 68:101–105CrossRefPubMed Kasapkara CS, Cinasal Demir G, Hasanoglu A, Tumer L (2014) Continuous glucose monitoring in children with glycogen storage disease type I. Eur J Clin Nutr 68:101–105CrossRefPubMed
Zurück zum Zitat Kishnani PS, Austin SL, Abdenur JE et al (2014) Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics. Genet Med : Off J Am Coll Med Genet 16, e1 Kishnani PS, Austin SL, Abdenur JE et al (2014) Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics. Genet Med : Off J Am Coll Med Genet 16, e1
Zurück zum Zitat Rake JP, Visser G, Labrune P et al (2002) Guidelines for management of glycogen storage disease type I - European Study on Glycogen Storage Disease Type I (ESGSD I). Eur J Pediatr 161(Suppl 1):S112–S119CrossRefPubMed Rake JP, Visser G, Labrune P et al (2002) Guidelines for management of glycogen storage disease type I - European Study on Glycogen Storage Disease Type I (ESGSD I). Eur J Pediatr 161(Suppl 1):S112–S119CrossRefPubMed
Zurück zum Zitat Riva M, Fessas D, Schiraldi A (2000) Starch retrogradation in cooked pasta and rice. Cereal Chem 77:433–438CrossRef Riva M, Fessas D, Schiraldi A (2000) Starch retrogradation in cooked pasta and rice. Cereal Chem 77:433–438CrossRef
Zurück zum Zitat Senn S (2002) Crossover trials in clinical research. Wiley Publishing, ChichesterCrossRef Senn S (2002) Crossover trials in clinical research. Wiley Publishing, ChichesterCrossRef
Zurück zum Zitat Shah KK, O'Dell SD (2013) Effect of dietary interventions in the maintenance of normoglycaemia in glycogen storage disease type 1a: a systematic review and meta-analysis. J Hum Nutr Diet : Off J Br Diet Assoc 26:329–339CrossRef Shah KK, O'Dell SD (2013) Effect of dietary interventions in the maintenance of normoglycaemia in glycogen storage disease type 1a: a systematic review and meta-analysis. J Hum Nutr Diet : Off J Br Diet Assoc 26:329–339CrossRef
Zurück zum Zitat Weinstein DA, Wolfsdorf JI (2002) Effect of continuous glucose therapy with uncooked cornstarch on the long-term clinical course of type 1a glycogen storage disease. Eur J Pediatr 161(Suppl 1):S35–S39CrossRefPubMed Weinstein DA, Wolfsdorf JI (2002) Effect of continuous glucose therapy with uncooked cornstarch on the long-term clinical course of type 1a glycogen storage disease. Eur J Pediatr 161(Suppl 1):S35–S39CrossRefPubMed
Zurück zum Zitat White FJ, Jones SA (2011) The use of continuous glucose monitoring in the practical management of glycogen storage disorders. J Inherit Metab Dis 34:631–642CrossRefPubMed White FJ, Jones SA (2011) The use of continuous glucose monitoring in the practical management of glycogen storage disorders. J Inherit Metab Dis 34:631–642CrossRefPubMed
Zurück zum Zitat Wiesli P, Brandle M, Schwegler B, Lehmann R, Spinas GA, Schmid C (2002) A plasma glucose concentration below 2.5 mmol L-1 is not an appropriate criterion to end the 72-h fast. J Intern Med 252:504–509CrossRefPubMed Wiesli P, Brandle M, Schwegler B, Lehmann R, Spinas GA, Schmid C (2002) A plasma glucose concentration below 2.5 mmol L-1 is not an appropriate criterion to end the 72-h fast. J Intern Med 252:504–509CrossRefPubMed
Zurück zum Zitat Wolever TM, Jenkins DJ, Kalmusky J et al (1986) Glycemic response to pasta: effect of surface area, degree of cooking, and protein enrichment. Diabetes Care 9:401–404CrossRefPubMed Wolever TM, Jenkins DJ, Kalmusky J et al (1986) Glycemic response to pasta: effect of surface area, degree of cooking, and protein enrichment. Diabetes Care 9:401–404CrossRefPubMed
Zurück zum Zitat Wolfsdorf JI, Crigler JF Jr (1997) Cornstarch regimens for nocturnal treatment of young adults with type I glycogen storage disease. Am J Clin Nutr 65:1507–1511PubMed Wolfsdorf JI, Crigler JF Jr (1997) Cornstarch regimens for nocturnal treatment of young adults with type I glycogen storage disease. Am J Clin Nutr 65:1507–1511PubMed
Metadaten
Titel
Alternative nighttime nutrition regimens in glycogen storage disease type I: a controlled crossover study
verfasst von
Michel Hochuli
Emanuel Christ
Fabian Meienberg
Roger Lehmann
Jan Krützfeldt
Matthias R. Baumgartner
Publikationsdatum
01.11.2015
Verlag
Springer Netherlands
Erschienen in
Journal of Inherited Metabolic Disease / Ausgabe 6/2015
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-015-9864-2

Weitere Artikel der Ausgabe 6/2015

Journal of Inherited Metabolic Disease 6/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.